Journal
NEUROLOGY
Volume 81, Issue 24, Pages 2073-2081Publisher
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1212/01.wnl.0000437308.22603.43
Keywords
-
Categories
Funding
- Canadian Institutes of Health Research
- Wellcome Trust Senior Fellow in Clinical Science [084980/Z/08/Z]
- Wellcome Trust Centre for Mitochondrial Research [096919Z/ 11/Z]
- Medical Research Council (UK) Centre for Translational Muscle Disease research
- Association Francaise contre les Myopathies
- EU FP7 TIRCON
- NIHR Newcastle Biomedical Research Centre based at Newcastle upon Tyne Hospitals NHS Foundation Trust
- Newcastle University
- Cambridge NIHR Biomedical Research Centre
- Wellcome Trust [084980/Z/08/Z] Funding Source: Wellcome Trust
- Medical Research Council [G1002570, G0701386] Funding Source: researchfish
- National Institute for Health Research [NF-SI-0509-10011, NF-SI-0508-10335] Funding Source: researchfish
- MRC [G0701386, G1002570] Funding Source: UKRI
Ask authors/readers for more resources
Objective: To determine whether the association between multiple sclerosis (MS) and Leber hereditary optic neuropathy (LHON) (known as Harding disease) is a chance finding, or the 2 disorders are mechanistically linked. Methods: We performed a United Kingdom-wide prospective cohort study of prevalent cases of MS with LHON mitochondrial DNA (mtDNA) mutations. The new cases were compared with published cases, enabling a comprehensive clinical description. We also performed a meta-analysis of studies screening patients with MS for LHON mtDNA mutations to find evidence of a genetic association. Results: Twelve new patients were identified from 11 pedigrees, and 44 cases were identified in the literature. The combined cohort had the following characteristics: multiple episodes of visual loss, predominance for women, and lengthy time interval before the fellow eye is affected (average 1.66 years), which is very atypical of LHON; conversely, most patients presented without eye pain and had a poor visual prognosis, which is unusual for optic neuritis associated with MS. The number of UK cases of LHON-MS fell well within the range predicted by the chance occurrence of MS and the mtDNA mutations known to cause LHON. There was no association between LHON mtDNA mutations and MS in a meta-analysis of the published data. Conclusions: Although the co-occurrence of MS and LHON mtDNA mutations is likely to be due to chance, the resulting disorder has a distinct phenotype, implicating a mechanistic interaction. Patients with LHON-MS have a more aggressive course, and prognostication and treatment should be guarded.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available